1. Discovery and characterization of a novel glucose-6-phosphate dehydrogenase (G6PD) inhibitor via high-throughput screening
   Zhongyuan Luo et al, 2021, Bioorganic & Medicinal Chemistry Letters CrossRef
2. Identification and verification of novel immune-related ferroptosis signature with excellent prognostic predictive and clinical guidance value in hepatocellular carcinoma
   Wenxiu Jiang et al, 2023, Frontiers in Genetics CrossRef
3. Identification of a venetoclax-resistance prognostic signature base on 6-senescence genes and its clinical significance for acute myeloid leukemia
   Peng Ke et al, 2023, Frontiers in Oncology CrossRef
4. Metabolic Reprogramming in Cancer: Implications for Immunosuppressive Microenvironment
   Durre Aden et al, 2025, Immunology CrossRef
5. Development and Validation of a Robust Ferroptosis-Related Gene Panel for Breast Cancer Disease-Specific Survival
   Pei Li et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
6. Use of signals of positive and negative selection to distinguish cancer genes and passenger genes
   László Bányai et al, 2021, eLife CrossRef
7. Caffeine Targets G6PDH to Disrupt Redox Homeostasis and Inhibit Renal Cell Carcinoma Proliferation
   Huanhuan Xu et al, 2020, Frontiers in Cell and Developmental Biology CrossRef
8. One-Pot Analytical Pipeline for Efficient and Sensitive Proteomic Analysis of Extracellular Vesicles
   Yi-Kai Liu et al, 2023, Journal of Proteome Research CrossRef
9. Glucose-6-phosphate dehydrogenase: a therapeutic target for ovarian cancer
   Chenxi Wang et al, 2023, Expert Opinion on Therapeutic Targets CrossRef
10. G6PD is a prognostic biomarker correlated with immune infiltrates in lung adenocarcinoma and pulmonary arterial hypertension
    Rongzhen Ding et al, 2024, Aging CrossRef
11. The Role of the Pentose Phosphate Pathway in Diabetes and Cancer
    Tongxin Ge et al, 2020, Frontiers in Endocrinology CrossRef
12. SLC25A21 Suppresses Cell Growth in Bladder Cancer via an Oxidative Stress-Mediated Mechanism
    Yong Wang et al, 2021, Frontiers in Oncology CrossRef
13. Identification of Energy Metabolism Genes for the Prediction of Survival in Hepatocellular Carcinoma
    Qinjunjie Chen et al, 2020, Frontiers in Oncology CrossRef
14. Recognition of Glycometabolism-Associated lncRNAs as Prognosis Markers for Bladder Cancer by an Innovative Prediction Model
    Dongdong Tang et al, 2022, Frontiers in Genetics CrossRef
15. PHGDH Is Upregulated at Translational Level and Implicated in Platin-Resistant in Ovarian Cancer Cells
    Fangfang Bi et al, 2021, Frontiers in Oncology CrossRef
16. Pan-cancer analysis reveals that G6PD is a prognostic biomarker and therapeutic target for a variety of cancers
    Tao Zeng et al, 2023, Frontiers in Oncology CrossRef
17. Disulfidptosis, A Novel Cell Death Pathway: Molecular Landscape and Therapeutic Implications
    Qiuyang Gu et al, 2024, Aging and disease CrossRef